1-L-MT can activate the p53 pathway by suppressing MDM2 expression and inhibiting DLBCL cell growth by inducing cell cycle arrest and apoptosis (Fig. 7). The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.